USNA

USANA Health Sciences Inc

USNA, USA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

https://www.usana.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
USNA
stock
USNA

Understanding Momentum Shifts in (USNA) Stock Traders Daily

Read more →
USNA
stock
USNA

Trading Action: What is the earnings history of USNA - July 2025 News Drivers & Low Drawdown Trading Strategies baoquankhu1.vn

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$39

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

High

21.66

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very Low

0.76

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-1.24 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.90 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-2.41 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.27

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 67.24% of the total shares of USANA Health Sciences Inc

1.

BlackRock Inc

(9.8152%)

since

2025/06/30

2.

Pzena Investment Management, LLC

(6.558%)

since

2025/06/30

3.

Renaissance Technologies Corp

(6.3203%)

since

2025/06/30

4.

Vanguard Group Inc

(5.5374%)

since

2025/06/30

5.

Dimensional Fund Advisors, Inc.

(4.9132%)

since

2025/06/30

6.

iShares Core S&P Small-Cap ETF

(3.6057%)

since

2025/08/31

7.

State Street Corp

(2.3333%)

since

2025/06/30

8.

Vanguard Total Stock Mkt Idx Inv

(1.9214%)

since

2025/07/31

9.

Jacobs Levy Equity Management, Inc.

(1.9188%)

since

2025/06/30

10.

Morgan Stanley - Brokerage Accounts

(1.8039%)

since

2025/06/30

11.

Geode Capital Management, LLC

(1.6995%)

since

2025/06/30

12.

iShares Russell 2000 ETF

(1.4822%)

since

2025/08/31

13.

American Century Companies Inc

(1.3957%)

since

2025/06/30

14.

Charles Schwab Investment Management Inc

(1.2486%)

since

2025/06/30

15.

Avantis US Small Cap Value ETF

(1.153%)

since

2025/08/30

16.

DFA US Small Cap Value I

(1.0164%)

since

2025/07/31

17.

Goldman Sachs Group Inc

(0.9132%)

since

2025/06/30

18.

Citadel Advisors Llc

(0.9105%)

since

2025/06/30

19.

Ameriprise Financial Inc

(0.8214%)

since

2025/06/30

20.

DFA US Targeted Value I

(0.7296%)

since

2025/07/31

21.

Vanguard Consumer Staples ETF

(0.7071%)

since

2025/07/31

22.

Nuveen Quant Small Cap Equity R6

(0.6945%)

since

2025/07/31

23.

Northern Trust Corp

(0.6826%)

since

2025/06/30

24.

Millennium Management LLC

(0.6704%)

since

2025/06/30

25.

Vanguard Institutional Extnd Mkt Idx Tr

(0.6299%)

since

2025/07/31

26.

Amvescap Plc.

(0.6108%)

since

2025/06/30

27.

Fidelity Small Cap Index

(0.6104%)

since

2025/06/30

28.

Dimensional US Targeted Value ETF

(0.6039%)

since

2025/08/29

29.

Assenagon Asset Management SA

(0.5714%)

since

2025/06/30

30.

Nuveen, LLC

(0.5548%)

since

2025/06/30

31.

iShares S&P Small-Cap 600 Value ETF

(0.546%)

since

2025/08/31

32.

iShares Russell 2000 Value ETF

(0.5459%)

since

2025/08/31

33.

Connor Clark & Lunn Inv Mgmt Ltd

(0.5338%)

since

2025/06/30

34.

Schwab Fundamental U.S. Small CompanyETF

(0.5147%)

since

2025/08/30

36.

Multi-Manager Small Cap Eq Strat Inst

(0.4704%)

since

2025/07/31

37.

DFA US Small Cap I

(0.4585%)

since

2025/07/31

38.

Pacer US Small Cap Cash Cows 100 ETF

(0.4572%)

since

2025/08/29

39.

Vanguard Strategic Equity Inv

(0.3947%)

since

2025/06/30

40.

Lazard US Sm Cap Eq WW Dist EUR

(0.3772%)

since

2025/05/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.15

EPS Estimate

0.65

EPS Difference

-0.8

Surprise Percent

-123.0769%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(6)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1.5)
Momentum
Strong Momentum(6.5)
Net Net
Not Undervalued (Net-Net)(3)
Quality
Moderate Quality(4)
Value
Undervalued(7.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.